Wolfe Research analyst Scott Group downgrades Saia (NASDAQ:SAIA) from Outperform to Peer Perform.
Atai Life Sciences Q1 2023 Results, Pipeline Update On DMT And Psilocybin Clinical Trials
Clinical-stage biopharma company atai Life Sciences (NASDAQ: ATAI) reported the financial results for its first quarter ended March 31, 2023, and provided the period’s business highlights.
Consolidated quarterly financials: